We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.
days to go: Expired investment: £1,493,593
MGB Biopharma is tackling the worldwide threat of antimicrobial resistance.   The company is in the process of clinical study and designing a new class of antibiotic.  They are looking for investment to start phase 2 of the study with 70% being supported by a grant.
days to go: Expired investment: £1,309,621
Visitret has developed the technology for low power, sunlight readable electronic displays for urban spaces.
days to go: Expired investment: £1,003
The Aspire Account has been created to address a major problem encountered by International Students coming to the UK to study at Universities. A UCAS study showed that 62.5% of international students ranked opening a UK Bank Account as one of their top 3 issues.
days to go: Expired investment: £140,174
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments. Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go: Expired investment: Withheld
Upgrade Pack is a software development company working towards transforming the way companies most valued customers and employees get access to discounts and travel upgrades. It is all about simplifying the whole process of flight and hotel upgrade by creating mutual value at the same time. To capture the global market, Upgrade Pack is not only launching in the UK and USA but also in Canada, Singapore, Hong Kong and Switzerland, and projecting a revenue of $240 million in 2019.
days to go: Expired investment: £587,085
SimplyCook offer a range of recipes to help cook restaurant quality meals in a fraction of the time. They have been rated as the top online recipe startup in the UK. Customers have currently cooked over 900,000 meals. With the investment recieved, SimplyCook aim to enhance their customers experience and launch a new distribution partnership with Ocado.  
days to go: Expired investment: £717,550
ShareOptic automatically assesses each share regardless of the device or cloud service being used in near real-time. Data shares are checked against dynamic blacklist and sanction lists and immediately and automatically blocked. ShareOptic wraps all cloud technology that enables data sharing, placing controls around the data so the user can be safe in the knowledge that ShareOptic is tracking who the data is shared with.
days to go: Expired investment: £5,909
Ceryx Medical is a medical technological entity that is developing bioelectronics based on a unique, patent-protected, chip technology that can mimic nerve centres within the body called Central Pattern Generators (CPGs). CPGs help to control a range of autonomic or rhythmical processes within the body such as peristalsis, heart rate, and even walking. The Ceryx system resembles a traditional cardiac pacing device that holds a lot of promise in potentially alleviating incidences of heart failure leading to a therapeutic effect on patient health. In the UK, this is a day surgery procedure under local anaesthetic with a basic system costing around £3500. The device, therefore, offers a cost-effective, single procedure solution for this currently intractable disease. Treatment expenditures on heart failure cases in the EU amount to almost £35 billion. The Ceryx system is a potential disruptor in this segment and offers multiple potential applications. The company is targeting £500,000 as part of £1 million round. With the investment, the company aims to produce a data package that mimics those used to support 510k/NDA applications, as mandated by the US Food and Drug Administration (FDA), for current devices and drugs used to treat heart failure.
days to go: Expired investment: Withheld
BIIM Casino is the first UK casino platform to open up to the world of casual gaming and offering social skill games. It blends the fun of skill games with the thrill of casinos. The UK Gambling Commission licensed the company as an Operator and a Software developer as well. The company has the capacity of producing at least one exclusive game every month. Furthermore, it is elected for Pitch ICE amidst the most innovative Gambling start-ups. The funds raised will be used to increase consumer acquisition and game production.
days to go: Expired investment: £80,150
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph